Rigel Pharmaceuticals (RIGL) Gross Margin Growth (1y) (2019 - 2026)

Rigel Pharmaceuticals (RIGL) Gross Margin Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Rigel Pharmaceuticals 681.25 Mn 534.56 Mn 54.21 Mn 44.00

Historic Data

Download Data
DateValue
Mar 31, 2026 44.00
Dec 31, 2025 152.00
Sep 30, 2025 767.00
Jun 30, 2025 319.00
Mar 31, 2025 -141.00
Dec 31, 2024 54.00
Sep 30, 2024 -1,000.00
Jun 30, 2024 -362.00
Mar 31, 2024 -311.00
Dec 31, 2023 -992.00
Sep 30, 2023 -339.00
Jun 30, 2023 -52.00
Mar 31, 2023 -302.00
Dec 31, 2022 172.00
Sep 30, 2022 -41.00
Jun 30, 2022 -298.00
Mar 31, 2022 -33.00
Dec 31, 2021 -65.00
Sep 30, 2021 6.00
Jun 30, 2021 125.00